Literature DB >> 22143670

Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells.

J Tanaka, J Sugita, S Shiratori, A Shigematu, S Asanuma, K Fujimoto, M Nishio, T Kondo, M Imamura.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22143670     DOI： 10.1038/leu.2011.345

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

2.  Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.

Authors:  Junji Tanaka; Norina Tanaka; Yan-Hua Wang; Kenjiro Mitsuhashi; Michiko Ryuzaki; Yuki Iizuka; Aya Watanabe; Midori Ishiyama; Akihito Shinohara; Hiroshi Kazama; Shotaro Hagiwara; Kentaro Yoshinaga; Yumi Kougen; Hirohito Kobayashi; Hitoshi Kanno; Masayuki Shiseki
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

Review 3.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

4.  Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Authors:  Jeannette Cany; Anniek B van der Waart; Jan Spanholtz; Marleen Tordoir; Joop H Jansen; Robbert van der Voort; Nicolaas M Schaap; Harry Dolstra
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

Review 5.  Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Authors:  M S Cairo; N Tarek; D A Lee; C Delaney
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 6.  Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.

Authors:  Gianfranco Pittari; Perla Filippini; Giusy Gentilcore; Jean-Charles Grivel; Sergio Rutella
Journal:  Front Immunol       Date:  2015-05-13       Impact factor: 7.561

Review 7.  Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Authors:  Robert Danby; Vanderson Rocha
Journal:  Front Immunol       Date:  2014-02-24       Impact factor: 7.561

Review 8.  Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Authors:  Anne M Dickinson; Jean Norden; Shuang Li; Ilona Hromadnikova; Christoph Schmid; Helga Schmetzer; Hans Jochem-Kolb
Journal:  Front Immunol       Date:  2017-06-07       Impact factor: 7.561

9.  Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.

Authors:  Jeannette Cany; Anniek B van der Waart; Marleen Tordoir; Gerben M Franssen; Basav N Hangalapura; Jolanda de Vries; Otto Boerman; Nicolaas Schaap; Robbert van der Voort; Jan Spanholtz; Harry Dolstra
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

10.  Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.

Authors:  U Koehl; C Kalberer; J Spanholtz; D A Lee; J S Miller; S Cooley; M Lowdell; L Uharek; H Klingemann; A Curti; W Leung; E Alici
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.